Imaging characteristics of an unusual, high-grade angiocentric glioma: a case report and review of the literature

J Radiol Case Rep. 2012 Oct;6(10):1-10. doi: 10.3941/jrcr.v6i10.1134. Epub 2012 Oct 1.

Abstract

Angiocentric gliomas have recently been reclassified as a separate central nervous system tumor. Few cases have been reported, and most of those correspond to slow-growing, low-grade neoplasms in very young pediatric patients. Here we describe magnetic resonance imaging findings (including diffusion imaging, spectroscopy and tractography) in an unusual higher-grade neoplasm with pathologic features suggestive of an angiocentric glioma in a 15-year-old male. The tumor had mild heterogeneous enhancement on magnetic resonance imaging, and a low apparent diffusion coefficient (9.9 × 10(-4) mm(2)s(-1)), consistent with an intermediate-to-high cellularity tumor. Spectroscopic imaging showed elevated choline/phosphocreatine and choline/N-acetyl aspartate ratios, suggesting an unusually aggressive tumor. We conclude that angiocentric glioma should not be excluded from consideration at primary diagnosis, particularly in teenaged patients nearing adulthood.

Keywords: MR imaging; MR spectroscopy; MR tractography; angiocentric glioma; diffusion tensor imaging.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adolescent
  • Brain Neoplasms / diagnosis*
  • Brain Neoplasms / pathology
  • Brain Neoplasms / therapy
  • Combined Modality Therapy
  • Cranial Nerve Diseases / etiology
  • Cranial Nerve Diseases / pathology*
  • Dacarbazine / analogs & derivatives
  • Dacarbazine / therapeutic use
  • Diagnosis, Differential
  • Ganglioglioma / diagnosis
  • Ganglioneuroma / diagnosis
  • Glioma / diagnosis*
  • Glioma / pathology
  • Glioma / therapy
  • Humans
  • Magnetic Resonance Imaging*
  • Male
  • Neoplasm Grading
  • Neoplasm Recurrence, Local / diagnosis*
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Recurrence, Local / therapy
  • Neuroectodermal Tumors, Primitive / diagnosis
  • Papilledema / etiology
  • Papilledema / pathology
  • Paresis / etiology
  • Paresis / pathology
  • Temozolomide
  • Treatment Outcome
  • Vision, Low

Substances

  • Dacarbazine
  • Temozolomide